🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
1.500
-0.020 (-1.32%)
Nov 18, 2026, 4:00 PM EST - Market closed

ZYBT Revenue

Zhengye Biotechnology Holding had revenue of 54.03M CNY in the half year ending December 31, 2025, a decrease of -43.00%. This brings the company's total for the last twelve months to 104.98M, down -31.71% year-over-year. In the year 2025, Zhengye Biotechnology Holding had annual revenue of 116.36M, down -37.56%. That makes Zhengye Biotechnology Holding the 35,299th largest company in the world by revenue and 4,632nd in the United States.

Revenue (ttm)
104.98M CNY
Revenue Growth
-31.71%
P/S Ratio
4.60
Revenue / Employee
390,264 CNY
Employees
269
Market Cap
71.09M USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025116.36M-69.99M-37.56%
Dec 31, 2024186.36M-25.30M-11.95%
Dec 31, 2023211.65M-48.62M-18.68%
Dec 31, 2022260.27M46.20M21.58%
Dec 31, 2021214.07M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.